Metraipolis › archive › dc_cec862db5108

Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors — Europe PMC PMID:42156379

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42156379
DOI
10.1038/s41467-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-01T14:25:09.982Z
SHA-256 of the archived text
04f6018d72647474305fa46898226b7de84e3d4991230307afe2180ae068ead9
Stable URL of this page
https://metraipolis.com/documento/dc_cec862db5108

How to cite

Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors — Europe PMC PMID:42156379 — Europe PMC (en), https://europepmc.org/article/MED/42156379 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cec862db5108 (Metraipolis archive dc_cec862db5108, sha256 04f6018d72647474305fa46898226b7de84e3d4991230307afe2180ae068ead9)
BibTeX
@misc{dccec862db5108,
  title = {Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors — Europe PMC PMID:42156379},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42156379},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cec862db5108; sha256 04f6018d72647474305fa46898226b7de84e3d4991230307afe2180ae068ead9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42156379. Agents can read the archived copy with the MCP tool read_document.